Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia.
Saved in:
| Title: | Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. |
|---|---|
| Authors: | Harris RD; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA.; Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA., Taylor OA; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA., Gramatges MM; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA., Hughes AE; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA., Zobeck M; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA., Pruitt S; Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA.; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA., Bernhardt MB; Deparment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Chavana A; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA., Huynh V; Children's Hospital of Orange County, University of California Irvine College of Medicine, Orange, CA, USA., Ludwig K; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Klesse L; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Heym K; Department of Hematology/Oncology, Cook Children's Medical Center, Fort Worth, TX, USA., Griffin T; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA., Erana R; Vannie E. Cook Children's Clinic, Cancer and Hematology Clinic, McAllen, TX, USA., Bernini JC; Vannie E. Cook Children's Clinic, Cancer and Hematology Clinic, McAllen, TX, USA., Choi A; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA., Ohno Y; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA., Richard MA; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA., Morrison AC; Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA., Chen H; Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA., Yu B; Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA., Lupo PJ; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA., Rabin KR; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA., Scheurer ME; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA., Brown AL; Texas Children's Hospital, Cancer and Hematology Center, Houston, TX, USA.; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Center for Epidemiology and Population Health, Houston, TX, USA. |
| Source: | The oncologist [Oncologist] 2025 Jun 04; Vol. 30 (6). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyaf055 |
